These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2752743)

  • 1. Contact allergy to bufexamac.
    Perret CM; Happle R
    Contact Dermatitis; 1989 Apr; 20(4):307-8. PubMed ID: 2752743
    [No Abstract]   [Full Text] [Related]  

  • 2. Contact dermatitis due to bufexamac.
    Watanabe K; Yoshikawa K
    Contact Dermatitis; 1983 Sep; 9(5):433. PubMed ID: 6627935
    [No Abstract]   [Full Text] [Related]  

  • 3. Contact sensitivity to bufexamac.
    Lachapelle JM
    Contact Dermatitis; 1975 Aug; 1(4):261. PubMed ID: 139242
    [No Abstract]   [Full Text] [Related]  

  • 4. [Contact allergy to bufexamac].
    Frosch PJ; Raulin C
    Hautarzt; 1987 Jun; 38(6):331-4. PubMed ID: 2958428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Contact allergies caused by bufexamac].
    Geier J; Fuchs T
    Med Klin (Munich); 1989 Jul; 84(7):333-8. PubMed ID: 2529420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contact allergy to bufexamac.
    Smeenk G
    Dermatologica; 1973; 147(5):334-7. PubMed ID: 4788476
    [No Abstract]   [Full Text] [Related]  

  • 7. Contact dermatitis due to bufexamac.
    Melino M; Bardazzi F; Manuzzi P
    Contact Dermatitis; 1987 May; 16(5):287. PubMed ID: 2957160
    [No Abstract]   [Full Text] [Related]  

  • 8. Contact dermatitis to bufexamac.
    Reiffers J
    Dermatologica; 1982 May; 164(5):354-6. PubMed ID: 7095225
    [No Abstract]   [Full Text] [Related]  

  • 9. Allergy to bufexamac.
    Van Hecke E
    Arch Belg Dermatol; 1973; 29(4):301-3. PubMed ID: 4802391
    [No Abstract]   [Full Text] [Related]  

  • 10. [Severe contact dermatitis caused by bufexamac with large flap desquamation].
    Landrieux C; Estève E; Serpier H; Kalis B
    Ann Dermatol Venereol; 1996; 123(3):198-9. PubMed ID: 8761786
    [No Abstract]   [Full Text] [Related]  

  • 11. [Severe contact dermatitis caused by Parfenac cream].
    Collet E; Lacroix M; Boulitrop Morvan C; Dalac S; Sallin J; Lambert D
    Ann Dermatol Venereol; 1993; 120(12):892-3. PubMed ID: 8074349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contact dermatitis caused by bufexamac sparing the eruption of herpes zoster.
    Fukuda H; Sato Y; Usami N; Yokouchi Y; Mukai H
    J Dermatol; 2012 Apr; 39(4):405-7. PubMed ID: 21950459
    [No Abstract]   [Full Text] [Related]  

  • 13. Contact allergy to antirheumatic drugs.
    Meneghini CL; Angelini G
    Contact Dermatitis; 1979 May; 5(3):197-8. PubMed ID: 455975
    [No Abstract]   [Full Text] [Related]  

  • 14. Contact allergy to ibuproxam.
    Molinini R
    Contact Dermatitis; 1991 Apr; 24(4):302-3. PubMed ID: 1831108
    [No Abstract]   [Full Text] [Related]  

  • 15. Allergic contact dermatitis to topical preparations of bufexamac.
    Pan Y; Nixon R
    Australas J Dermatol; 2012 Aug; 53(3):207-10. PubMed ID: 22881467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contact sensitivity to oxyphenbutazone.
    Valsecchi R; Serra M; Foiadelli L; Cainelli T
    Contact Dermatitis; 1981 May; 7(3):157. PubMed ID: 7273732
    [No Abstract]   [Full Text] [Related]  

  • 17. [A common and insidious side-effect: allergic contact dermatitis caused by bufexamac used in the treatment of dermatitis. Results from the Information Network of Departments of Dermatology (IDVK)].
    Schnuch A; Gefeller O; Uter W
    Dtsch Med Wochenschr; 2005 Dec; 130(50):2881-6. PubMed ID: 16342011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bufexamac: a review of its pharmacological properties and therapeutic efficacy in inflammatory dermatoses.
    Brogden RN; Pinder RM; Sawyer PR; Speight TM; Avery GS
    Drugs; 1975; 10(5-6):351-6. PubMed ID: 1204506
    [No Abstract]   [Full Text] [Related]  

  • 19. [Severe allergic contact dermatitis with generalized spread due to bufexamac presenting as the "baboon" syndrome].
    Proske S; Uter W; Schnuch A; Hartschuh W
    Dtsch Med Wochenschr; 2003 Mar; 128(11):545-7. PubMed ID: 12635026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological significance of bufexamac as a frequent and relevant contact sensitizer.
    Kränke B; Szolar-Platzer C; Komericki P; Derhaschnig J; Aberer W
    Contact Dermatitis; 1997 Apr; 36(4):212-5. PubMed ID: 9165205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.